Various Advanced Cancer

6 clinical trials · Condition

Record	Firm	Date
A Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus Cisplatin (NCT03143153)	Bristol-Myers Squibb	2017-06-29
A Study to Evaluate the Safety and Efficacy of Nivolumab Monotherapy and Nivolumab in Combination With Ipilimumab in Pediatric Participants With High Grade Primary Central Nervous System (CNS) Malignancies (NCT03130959)	Bristol-Myers Squibb	2017-06-12
An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer (NCT02632409)	Bristol-Myers Squibb	2016-03-22
An Investigational Immuno-therapy Study to Investigate the Safety and Effectiveness of Nivolumab, and Nivolumab Combination Therapy in Virus-associated Tumors (NCT02488759)	Bristol-Myers Squibb	2015-10-13
A Study of Nivolumab in Participants With Metastatic or Unresectable Bladder Cancer (NCT02387996)	Bristol-Myers Squibb	2015-03-09
Phase I Ascending Multiple-Dose Study of BMS-986115 in Subjects With Advanced Solid Tumors (NCT01986218)	Bristol-Myers Squibb	2013-11-01

Every clearance here is in the API, with alerts when new ones post.